TREVI THERAPEUTICS INC (TRVI:NASDAQ)
$12.51 -0.1 (-0.793%)
Analysed TREVI THERAPEUTICS INC (TRVI:NASDAQ) News Sources
Trevi Therapeutics Q1 Earnings Call Highlights
06-05-2026
marketbeat.com
Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
05-05-2026
yahoo.com
Trevi Therapeutics Maps Haduvio Chronic Cough Push, Sees Cash Runway Into 2030
09-05-2026
marketbeat.com
Trevi Therapeutics Is Up 100%, Pivotal bioVenture Adds Anyway. Here's Why That Matters.
03-06-2026
fool.com
Trevi Therapeutics Announces Upcoming June and July Event Schedule
17-06-2026
yahoo.com
Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
30-07-2026
yahoo.com
Trevi Therapeutics to Participate in Upcoming September Conferences
03-09-2026
yahoo.com
Trevi Therapeutics (TRVI) Stock Trades At A Premium To Fair Value
05-09-2026
yahoo.com
Trevi Therapeutics Announces Oral Presentation Accepted at the CHEST 2026 Annual Meeting
13-10-2026
yahoo.com
Do Trevi Therapeutics’ (TRVI) CORAL Data and GSK’s Exit Reframe Its Chronic Cough Ambitions?
13-10-2026
yahoo.com
What is the current price of TREVI THERAPEUTICS INC (TRVI:NASDAQ)?
The current price of TREVI THERAPEUTICS INC (TRVI:NASDAQ) is $12.51.
TREVI THERAPEUTICS INC (TRVI:NASDAQ) absolute price change since previous trading day?
The absolute price change of TREVI THERAPEUTICS INC (TRVI:NASDAQ) since the previous trading day is $-0.1.
TREVI THERAPEUTICS INC (TRVI:NASDAQ) percentage price change since previous trading day?
The percentage price change of TREVI THERAPEUTICS INC (TRVI:NASDAQ) since the previous trading day is -0.793%.
What is the most recent average sentiment score for TREVI THERAPEUTICS INC (TRVI:NASDAQ)?
The most recent average sentiment score for TREVI THERAPEUTICS INC (TRVI:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for TREVI THERAPEUTICS INC (TRVI:NASDAQ)?
The most recent sentiment for TREVI THERAPEUTICS INC (TRVI:NASDAQ) is .
SEC-8K** Filing Available For TREVI THERAPEUTICS INC (TRVI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.